Genmab (NASDAQ:GMAB) reported its Q1 earnings results on Wednesday, May 10, 2023 at 11:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Genmab missed estimated earnings by 92.31%, reporting an EPS of $0.05 versus an estimate of $0.65.
Revenue was up $91.68 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $3.06 which was followed by a 1.58% drop in the share price the next day.
Here’s a look at Genmab’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | 3.18 | 1.63 | 1.58 | |
| EPS Actual | 0.12 | 0.53 | 0.41 | 0.11 |
| Revenue Estimate | 664.17M | 475.35M | 404.75M | 319.59M |
| Revenue Actual | 699.51M | 553.75M | 453.01M | 319.67M |
To track all earnings releases for Genmab visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
